CARDIOL THERAPEUTICS INC-ACRDL
ASignal's systematic analysis rates CRDL as Neutral.
Reflects the latest available analysis · analyzed Oct 10, 2026
The case on CRDL
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong financial health score (0.9)
- High cash position with $26.08M in total cash
- Low debt-to-equity ratio (0.00x)
- Current ratio of 5.55x indicating strong liquidity
- Positive Reddit retail interest with 10 mentions
- Negative MACD histogram suggesting weakening momentum
- Negative operating and net margins (0.00%)
- Negative return on equity (-190.18%) and return on assets (-90.92%)
- Negative free cash flow (-$15.48M) and operating cash flow (-$24.05M)
- Only one news source (cnn.com) with minimal coverage
- Price significantly below 20-day EMA (1.61 vs 1.23)
See the full verdict on CRDL
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes CRDL
Most investors never get a second opinion, let alone several. ASignal runs CRDL past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.